Age Associated Sarcopenia refers to the progressive and generalized skeletal muscle disorder characterized by the concurrent loss of muscle mass and strength or function occurring with advancing age. Clinically, this represents a significant deviation from optimal physiological aging trajectories. We observe a reduction in muscle fiber cross-sectional area and a shift toward adipose infiltration within the musculature. This condition fundamentally impacts mobility and metabolic homeostasis in older adults.
Origin
Sarcopenia originates from the Greek words sarx (flesh) and penia (loss), explicitly denoting muscle wasting. Its association with age signifies the multifactorial nature of age-related anabolic resistance. The term is used across geriatrics and physiology to standardize the description of age-related decline in muscle quality. Understanding this origin helps frame interventions aimed at anabolic support.
Mechanism
The mechanism involves an imbalance between muscle protein synthesis (MPS) and muscle protein breakdown (MPB), favoring catabolism over anabolism as decades progress. Decreased sensitivity to anabolic stimuli, such as resistance exercise and amino acid availability, plays a critical role. Furthermore, age-related changes in growth hormone and testosterone profiles contribute to reduced satellite cell function and subsequent regeneration capacity. Mitochondrial dysfunction within myocytes exacerbates this systemic decline.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.